NCT00596609

Brief Summary

Patients undergoing posterior spinal fusion (PSF) procedures for scoliosis are at risk for iatrogenic neurologic injury of the spinal cord and/or spinal nerve roots during surgical correction of the abnormal spinal curvature. The degree of neurologic injury can range from minor sensory deficits to complete paraplegia. Surgeons at CHOP utilize neurophysiologists to identify impending neurologic injury. These consultants monitor spinal cord pathways by recording and analyzing evoked potentials during the operation. Evoked potentials are low voltage electrical signals generated in response to transcranial or transcutaneous electrical stimulation of motor and sensory neural pathways. Some patients undergoing PSF receive an injection of morphine into the cerebrospinal fluid during the operation. This intrathecal (IT) morphine has potent analgesic effects. While most commonly used anesthetic agents have well-characterized effects on evoked potentials, little data exists on the effects of IT morphine on transcranial electric motor-evoked potentials (TceMEPs). This is a prospective observational study to characterize the effects of IT morphine on TceMEPs.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2007

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2007

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2008

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 17, 2008

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2009

Completed
Last Updated

September 16, 2009

Status Verified

September 1, 2009

Enrollment Period

1.7 years

First QC Date

January 9, 2008

Last Update Submit

September 14, 2009

Conditions

Keywords

Injections, intrathecalTranscranialSpinal FusionEvoked Potentials, Motor

Outcome Measures

Primary Outcomes (1)

  • To quantitatively evaluate the effects of IT morphine on TceMEP amplitude and latency in patients undergoing PSF who have IT morphine injected after instrumentation

    30 minute period - Group 1 - after IT morphine injection or during skin closure for Group 2.

Study Arms (2)

1

Group 1 will be subjects who receive Intrathecal Morphine.

Drug: Intrathecal Morphine

2

Group 2 will be subjects who do not receive Intrathecal Morphine.

Interventions

* In the IT morphine group, prior to IT morphine injection (within 15 minutes of the injection), the neurophysiologist will be asked to obtain a set of TceMEP recordings. The recordings collected at this time will be labeled "Baseline." These will serve as controls for subsequent recording comparisons. * In the IT morphine group, the time of IT morphine injection will be recorded, as well as the dose. A timer will be started. The neurophysiologist will then be asked to collect four additional sets of TceMEP recordings, at 5, 10, 20, and 30 minutes after morphine injection.

1

Eligibility Criteria

Age11 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Children ages 11-18 with idiopathic scoliosis who are scheduled to have a posterior spinal fusion.

You may qualify if:

  • Intrathecal Morphine Group:
  • All patients with idiopathic scoliosis aged 11 through and including 18 who present to CHOP for posterior spinal fusion will be eligible
  • Patients with procedures anticipated to extend to or below the second lumbar vertebral level
  • Only patients given intrathecal morphine after curve correction and instrumentation will be studied
  • Control Group:
  • All patients with idiopathic scoliosis aged 11 through and including 18 who present to CHOP for posterior spinal fusion will be eligible
  • Patients with procedures not anticipated to extend to or below the second lumbar vertebral level
  • Patients who do not receive IT morphine injection as part of their routine anesthetic care

You may not qualify if:

  • Intrathecal Morphine Group:
  • Patients who receive inhaled anesthetic agents before or during the 30 minutes following IT morphine injection
  • Patients who receive neuromuscular blocking drugs within an hour before or during the 30 minutes following IT morphine injection.
  • Patients who develop significant changes in TceMEPs prior to intrathecal morphine injection
  • Patients with intraoperative hemodynamic instability which requires continuous vasoactive drug infusion (e.g., dopamine)
  • Patients with neuromuscular, congenital, or other non-idiopathic scoliosis
  • Pregnant or lactating females
  • Control Group:
  • Patients who receive inhaled anesthetic agents before or during the 30 minutes following IT morphine injection
  • Patients who receive neuromuscular blocking drugs within an hour before or during the 30 minutes following IT morphine injection.
  • Patients who develop significant changes in TceMEPs prior to the study interval
  • Patients with intraoperative hemodynamic instability which requires continuous vasoactive drug infusion (e.g., dopamine)
  • Patients with neuromuscular, congenital, or other non-idiopathic scoliosis
  • Pregnant or lactating females

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Children's Hospital of Philadephia

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Trauma, Nervous System

Condition Hierarchy (Ancestors)

Nervous System DiseasesWounds and Injuries

Study Officials

  • Paul Stricker, MD

    Children's Anesthesiology Associates, Ltd.

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 9, 2008

First Posted

January 17, 2008

Study Start

August 1, 2007

Primary Completion

April 1, 2009

Study Completion

April 1, 2009

Last Updated

September 16, 2009

Record last verified: 2009-09

Locations